Growth Metrics

Envoy Medical (COCH) Cost of Revenue (2022 - 2026)

Envoy Medical's Cost of Revenue history spans 5 years, with the latest figure at $313000.0 for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 38.5% to $313000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 million, a 134.68% increase, with the full-year FY2025 number at $1.2 million, up 64.42% from a year prior.
  • Cost of Revenue hit $313000.0 in Q1 2026 for Envoy Medical, down from $557000.0 in the prior quarter.
  • Over the last five years, Cost of Revenue for COCH hit a ceiling of $557000.0 in Q4 2025 and a floor of -$474000.0 in Q4 2024.
  • Historically, Cost of Revenue has averaged $279866.7 across 5 years, with a median of $313000.0 in 2026.
  • Biggest five-year swings in Cost of Revenue: surged 276.42% in 2023 and later tumbled 192.4% in 2024.
  • Tracing COCH's Cost of Revenue over 5 years: stood at $538000.0 in 2022, then decreased by 4.65% to $513000.0 in 2023, then tumbled by 192.4% to -$474000.0 in 2024, then soared by 217.51% to $557000.0 in 2025, then crashed by 43.81% to $313000.0 in 2026.
  • Business Quant data shows Cost of Revenue for COCH at $313000.0 in Q1 2026, $557000.0 in Q4 2025, and $405000.0 in Q3 2025.